NB
NovaBay Pharmaceuticals, Inc.
NBY · AMEX
$1.88 -3.59% (-$0.07)
Piotroski F-Score Weak
3/9Valuation
-
N/A PEG N/A
P/E N/A
P/B N/A
Growth
-
N/A FCF growth N/A
EPS growth N/A
Book val. growth N/A
Profitability
-
N/A Op. margin N/A
Gross margin N/A
FCF margin N/A
Quality
-
N/A ROA N/A
ROIC N/A
Asset turnover N/A
Debt
-
N/A Int. coverage N/A
Debt/Equity N/A
Net debt/EBITDA N/A
Stability
0 /100
Unstable Beta 0.16x
Profitable years N/A
Rev. volatility N/A
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about NBY
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Michael Kazley
Employees
13
Headquarters
EmeryVille